Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease

Digestive Diseases and Sciences

Volumn 61, Issue 7, 2016, Pages 2019-2026

  Adam, Birgit ^a   Koldehoff, Michael ^b   Ditschkowski, Markus ^b   Gromke, Tanja ^b   Hlinka, Michal ^b   Trenschel, Rudolf ^b   Kordeals, Lambros ^b   Steckel, Nina K ^b   Beelen, Dietrich W ^b   Liebregts, Tobias ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

CMV colitis; Colonoscopy; Diarrhea; Fecal calprotectin; Graft versus host disease; Hematopoietic stem cell transplantation

Indexed keywords

CALGRANULIN; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLATE MOFETIL; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; BIOLOGICAL MARKER;

ABDOMINAL CRAMP; ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRISTOL STOOL SCALE; COLITIS; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FECES LEVEL; FEMALE; FOLLOW UP; GASTROINTESTINAL GRAFT VERSUS HOST DISEASE; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOPROPHYLAXIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FECES LEVEL; SKIN GRAFT VERSUS HOST DISEASE; STOMACH MUCOSA LESION; ADVERSE EFFECTS; CHEMISTRY; FECES; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; FECES; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84961198116     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4112-7     Document Type: Article

References (22)

1. Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet. 2009;373:1550–1561.
2. Weisdorf D, Haake R, Blazar B, et al. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood. 1990;75:1024–1030.
3. Bastos OM, Castilla-Llorente C, de la Guia AL, et al. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease. Bone Marrow Transplant. 2012;47:1241–1242.
4. Chiusolo P, Metafuni E, Giammarco S, et al. Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation. Blood. 2012;120:4443–4444.
5. Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–828.
6. Adam B, Liebregts T, Saadat-Gilani K, et al. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Aliment Pharmacol Ther. 2005;22:357–363.
7. Heaton KW, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33:818–824.
8. Kreisel W, Dahlberg M, Bertz H, et al. Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant. 2012;47:430–438.
9. Lerner KG, Kao GF, Storb R, et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974;6:367–371.
10. Weisdorf DJ, Snover DC, Haake R, et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood. 1990;76:624–629.
11. Dignan FL, Clark A, Amrolia P, et al. Diagnosis and management of acute graft-versus-host disease. Br J Haematol. 2012;158:30–45.
12. O’Meara A, Kapel N, Xhaard A, et al. Fecal calprotectin and alpha1-antitrypsin dynamics in gastrointestinal GvHD. Bone Marrow Transplant. 2015;50:1105–1109.
13. Liu J, Kong J, Chang YJ, et al. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect. 2015;21:1121.e9–1121.e15.
14. Martinez C, Rosales M, Calvo X, et al. Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT. Bone Marrow Transplant. 2012;47:694–699.
15. Johansson JE, Nilsson O, Stotzer PO. Colonoscopy and sigmoidoscopy are equally effective for the diagnosis of colonic acute graft-versus-host disease in patients with diarrhea after allogeneic stem cell transplantation: a prospective controlled trial. Biol Blood Marrow Transplant. 2015;21:2086–2090.
16. Liu A, Meyer E, Johnston L, et al. Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms. Aliment Pharmacol Ther. 2013;38:955–966.
17. Rodriguez-Otero P, Porcher R, de Peffault LR, et al. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease. Blood. 2012;119:5909–5917.
18. MacMillan ML, Defor TE, Weisdorf DJ. What predicts high risk acute graft-versus-host disease (GVHD) at onset? Identification of those at highest risk by a novel acute GVHD risk score. Br J Haematol. 2012;157:732–741.
19. MacMillan ML, Robin M, Harris AC, et al. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant. 2015;21:761–767.
20. Cerrillo E, Beltran B, Pous S, et al. Fecal calprotectin in ileal crohn’s disease: relationship with magnetic resonance enterography and a pathology score. Inflamm Bowel Dis. 2015;21:1572–1579.
21. Olsen PA, Fossmark R, Qvigstad G. Fecal calprotectin in patients with suspected small bowel disease—a selection tool for small bowel capsule endoscopy? Scand J Gastroenterol. 2015;50:272–277.
22. Hoog CM, Bark LA, Brostrom O, et al. Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small-bowel Crohn’s disease. Scand J Gastroenterol. 2014;49:1084–1090.